» Articles » PMID: 14674716

Co-inheritance of Specific Genotypes of HSPG and ApoE Gene Increases Risk of Type 2 Diabetic Nephropathy

Overview
Publisher Springer
Specialty Biochemistry
Date 2003 Dec 17
PMID 14674716
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this paper is to investigate co-inheritance of specific HSPG and ApoE genotypes in the development of Chinese type 2 diabetic nephropathy. PCR-RFLP was used to detect HSPG and ApoE genotypes in 385 Chinese subjects including 298 patients with type 2 diabetes mellitus (T2DM) and 87 non-diabetic controls (Non-DM). The T2DM group was subdivided into patients with (TDN; n = 218) and without diabetic nephropathy (Non-DN; n = 80). The latter group was further subdivided into groups of patients with microalbuminuria nephropathy (DN-1; n = 129) and severe diabetic nephropathy (DN-2; n = 89). We then compared the relative frequencies of various HSPG and ApoE genotypes and alleles among the groups, searching for predictive trends. The T allele of the HSPG gene occurred more frequently in the DN-2 group than in the Non-DN or DN-1 groups, their Fisher's exact p was 1.05 x 10(-3) and 6.58 x 10(-6); odds ratios were 2.09 (95% CI 1.32-3.30) and 2.48 (95% CI 1.64-3.74), respectively. The E2 allele of the ApoE gene occurred more frequently in the T2DM than in the Non-DM group, the Fisher's exact p was 0.0087; odds ratio was 3.45 (95% CI 1.30-9.81). Genotype analysis showed that the TT or TG of HSPG gene were paired with the E2/2 or E2/3 of ApoE gene significantly more frequently in the TDN group than in the Non-DN group, with an odds ratio of 3.03 (95% CI 1.03-8.90). There was no significant differences in other combinations of genotypes in HSPG and ApoE genes between TDN and Non-DN group. These results suggest that the HSPG T allele is a risk factor for the development of severe diabetic nephropathy in type 2 diabetic patients, and that the ApoE E2 allele is a risk factor for the occurrence of type 2 diabetes mellitus in Chinese general population. In addition, we find that co-inheritance of T/E2 confers a higher risk of type 2 diabetes mellitus progression to diabetic nephropathy in Chinese.

Citing Articles

The impact of PPARγ and ApoE gene polymorphisms on susceptibility to diabetic kidney disease in type 2 diabetes mellitus: a meta-analysis.

Taurbekova B, Mukhtarova K, Salpynov Z, Atageldiyeva K, Sarria-Santamera A BMC Nephrol. 2024; 25(1):436.

PMID: 39614174 PMC: 11607899. DOI: 10.1186/s12882-024-03859-6.


ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis.

Shi J, Cheng Z, Qiu S, Cui H, Gu Y, Zhao Q Lipids Health Dis. 2020; 19(1):136.

PMID: 32534589 PMC: 7293775. DOI: 10.1186/s12944-020-01307-6.


The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.

Li T, Shi Y, Yin J, Qin Q, Wei S, Nie S Int Urol Nephrol. 2014; 47(1):117-30.

PMID: 25262148 DOI: 10.1007/s11255-014-0843-6.


Apo E gene polymorphism affects development of type 2 diabetic nephropathy in Asian populations, especially in East Asians: an updated meta-analysis.

Lin Y, Pan J, Jiang M, Tan J, Zhong W, Gong T Med Sci Monit. 2014; 20:1596-603.

PMID: 25196797 PMC: 4166221. DOI: 10.12659/MSM.892111.


APOE polymorphism and diabetic nephropathy.

Araki S Clin Exp Nephrol. 2013; 18(2):230-3.

PMID: 24026386 DOI: 10.1007/s10157-013-0862-0.


References
1.
Mahley R, Innerarity T . Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta. 1983; 737(2):197-222. DOI: 10.1016/0304-4157(83)90001-1. View

2.
Lindahl U, Kusche M, Lidholt K, Oscarsson L . Biosynthesis of heparin and heparan sulfate. Ann N Y Acad Sci. 1989; 556:36-50. DOI: 10.1111/j.1749-6632.1989.tb22488.x. View

3.
Ukkola O, Kervinen K, Salmela P, von Dickhoff K, Laakso M, Kesaniemi Y . Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis. 1993; 101(1):9-15. DOI: 10.1016/0021-9150(93)90096-d. View

4.
Chowdhury T, Dyer P, Kumar S, Barnett A, Bain S . Genetic determinants of diabetic nephropathy. Clin Sci (Lond). 1999; 96(3):221-30. View

5.
Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M . Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis. 2002; 40(2):243-51. DOI: 10.1053/ajkd.2002.34502. View